The University of Southampton
University of Southampton Institutional Repository

Blood pressure measurement and adverse pregnancy outcomes - a cohort study testing blood pressure variability and alternatives to 140/90mmHg

Blood pressure measurement and adverse pregnancy outcomes - a cohort study testing blood pressure variability and alternatives to 140/90mmHg
Blood pressure measurement and adverse pregnancy outcomes - a cohort study testing blood pressure variability and alternatives to 140/90mmHg
Objective: to examine the relationship with adverse pregnancy outcomes of: (1) American College of Cardiology/American Heart Association blood pressure (BP) thresholds, and (2) visit-to-visit BP variability (BPV), adjusted for BP level.

Design: an observational study.

Setting: analysis of data from the population-based UK Southampton Women’s Survey (SWS).

Population or Sample: 3003 SWS participants.

Methods: generalised estimating equations were used to estimate crude and adjusted relative risks (RRs) of adverse pregnancy outcomes by BP thresholds, and by BPV (as standard deviation [SD], average real variability [ARV], and variability independent of the mean [VIM]). Likelihood ratios (LRs) were calculated to evaluate diagnostic test properties, for BP at or above a threshold, compared with those below.

Main Outcome Measures: gestational hypertension, severe hypertension, pre-eclampsia, preterm birth (PTB), small-for-gestational-age (SGA) infants, neonatal intensive care unit (NICU) admission.

Results: a median of 11 BP measurements were included per participant. For BP at ≥20 weeks’ gestation, higher BP was associated with more adverse pregnancy outcomes; however, only BP <140/90mmHg was a good rule-out test (negative LR <0.20) for pre-eclampsia, and BP ≥140/90mmHg a good rule-in test (positive LR >8.00) for the condition. BP ≥160/110mmHg could rule-in PTB, SGA infants, and NICU admission (positive LR >5.0). Higher BPV (by SD, ARV, or VIM) was associated with gestational hypertension, severe hypertension, pre-eclampsia, PTB, SGA, and NICU admission (adjusted RRs 1.05-1.39).

Conclusions: while our findings do not support lowering the BP threshold for pregnancy hypertension, they suggest BPV could be useful to identify elevated risk of adverse outcomes.


1470-0328
Wilson, Milly G.
c1ea95d3-83c2-4771-9e5f-f7fa735d8a85
Bone, Jeffrey N.
da2cde17-ff5d-465e-8a01-472268eac8ed
Slade, Laura
5287c25a-318a-4d8a-a43e-20a8f0162101
Mistry, Hiten D.
f34ad4f6-c76b-4be1-b853-51acd80b0ce7
Singer, Joel
0d909cb1-3062-46e1-93e8-258214dfac18
Crozier, Sarah R.
9c3595ce-45b0-44fa-8c4c-4c555e628a03
Godfrey, Keith M.
0931701e-fe2c-44b5-8f0d-ec5c7477a6fd
Baird, Janis
f4bf2039-6118-436f-ab69-df8b4d17f824
von Dadelszen, Peter
99289cc7-421a-405b-b2b7-9636ec4818e8
Magee, Laura A.
6aaef1bb-9a91-4014-bc6a-491f7506886a
Wilson, Milly G.
c1ea95d3-83c2-4771-9e5f-f7fa735d8a85
Bone, Jeffrey N.
da2cde17-ff5d-465e-8a01-472268eac8ed
Slade, Laura
5287c25a-318a-4d8a-a43e-20a8f0162101
Mistry, Hiten D.
f34ad4f6-c76b-4be1-b853-51acd80b0ce7
Singer, Joel
0d909cb1-3062-46e1-93e8-258214dfac18
Crozier, Sarah R.
9c3595ce-45b0-44fa-8c4c-4c555e628a03
Godfrey, Keith M.
0931701e-fe2c-44b5-8f0d-ec5c7477a6fd
Baird, Janis
f4bf2039-6118-436f-ab69-df8b4d17f824
von Dadelszen, Peter
99289cc7-421a-405b-b2b7-9636ec4818e8
Magee, Laura A.
6aaef1bb-9a91-4014-bc6a-491f7506886a

Wilson, Milly G., Bone, Jeffrey N., Slade, Laura, Mistry, Hiten D., Singer, Joel, Crozier, Sarah R., Godfrey, Keith M., Baird, Janis, von Dadelszen, Peter and Magee, Laura A. (2023) Blood pressure measurement and adverse pregnancy outcomes - a cohort study testing blood pressure variability and alternatives to 140/90mmHg. BJOG: An International Journal of Obstetrics & Gynaecology. (In Press)

Record type: Article

Abstract

Objective: to examine the relationship with adverse pregnancy outcomes of: (1) American College of Cardiology/American Heart Association blood pressure (BP) thresholds, and (2) visit-to-visit BP variability (BPV), adjusted for BP level.

Design: an observational study.

Setting: analysis of data from the population-based UK Southampton Women’s Survey (SWS).

Population or Sample: 3003 SWS participants.

Methods: generalised estimating equations were used to estimate crude and adjusted relative risks (RRs) of adverse pregnancy outcomes by BP thresholds, and by BPV (as standard deviation [SD], average real variability [ARV], and variability independent of the mean [VIM]). Likelihood ratios (LRs) were calculated to evaluate diagnostic test properties, for BP at or above a threshold, compared with those below.

Main Outcome Measures: gestational hypertension, severe hypertension, pre-eclampsia, preterm birth (PTB), small-for-gestational-age (SGA) infants, neonatal intensive care unit (NICU) admission.

Results: a median of 11 BP measurements were included per participant. For BP at ≥20 weeks’ gestation, higher BP was associated with more adverse pregnancy outcomes; however, only BP <140/90mmHg was a good rule-out test (negative LR <0.20) for pre-eclampsia, and BP ≥140/90mmHg a good rule-in test (positive LR >8.00) for the condition. BP ≥160/110mmHg could rule-in PTB, SGA infants, and NICU admission (positive LR >5.0). Higher BPV (by SD, ARV, or VIM) was associated with gestational hypertension, severe hypertension, pre-eclampsia, PTB, SGA, and NICU admission (adjusted RRs 1.05-1.39).

Conclusions: while our findings do not support lowering the BP threshold for pregnancy hypertension, they suggest BPV could be useful to identify elevated risk of adverse outcomes.


Text
SWS Manuscript R1 - 20230919 - Accepted Manuscript
Available under License Creative Commons Attribution.
Download (241kB)

More information

Accepted/In Press date: 7 November 2023
Additional Information: Funding: M. Wilson was funded by the KCL Centre for Doctoral Training in Data-Driven Health (ST12512). The PRECISE Network is funded by the UK Research and Innovation Grand Challenges Research Fund GROW Award scheme (MR/P027938/1). KMG is supported by the UK Medical Research Council (MC_UU_12011/4), the National Institute for Health Research (NIHR Senior Investigator (NF-SI-0515-10042) and NIHR Southampton Biomedical Research Centre (NIHR203319)), and the British Heart Foundation (RG/15/17/3174, SP/F/21/150013). For Open Access, the author has applied a Creative Commons Attribution (CC BY) licence to any Author Accepted Manuscript version arising from this submission. This work was supported by funding from a UK Research and Innovation Global Challenges Research Fund (GCRF) GROW award (MR/P027938/1).

Identifiers

Local EPrints ID: 484813
URI: http://eprints.soton.ac.uk/id/eprint/484813
ISSN: 1470-0328
PURE UUID: 369cef95-14a7-49e5-9a60-ff365552b9c3
ORCID for Sarah R. Crozier: ORCID iD orcid.org/0000-0002-9524-1127
ORCID for Keith M. Godfrey: ORCID iD orcid.org/0000-0002-4643-0618
ORCID for Janis Baird: ORCID iD orcid.org/0000-0002-4039-4361

Catalogue record

Date deposited: 22 Nov 2023 17:33
Last modified: 14 Aug 2024 01:38

Export record

Contributors

Author: Milly G. Wilson
Author: Jeffrey N. Bone
Author: Laura Slade
Author: Hiten D. Mistry
Author: Joel Singer
Author: Janis Baird ORCID iD
Author: Peter von Dadelszen
Author: Laura A. Magee

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×